AGORA | AFC organizes workshop on the topic of Bio-similars
post-template-default,single,single-post,postid-11670,single-format-standard,edgt-core-1.0,ajax_fade,page_not_loaded,,hudson child-child-ver-1.0.0,hudson-ver-1.9,vertical_menu_enabled, vertical_menu_left, vertical_menu_width_290,smooth_scroll,side_menu_slide_from_right,blog_installed,wpb-js-composer js-comp-ver-5.2,vc_responsive

AFC organizes workshop on the topic of Bio-similars

On the 22nd of May, AFC organized an information event on the topic of “bio-similars” at Galaxy Hotel in Heraklion. The event, was held in two parts and gathered 70 participants. In the beginning there was a welcome speech under the title “What I need to know about Bio-similars” following by a Patients Workshop on “What I do not know about Bio-similars!”, where more than 40 participants had the opportunity to participate at a constructive discussion about Bio-similars and their treatments.

Dr. Avgoustidis, rheumatologist, during his speech, referred to Biosimilars, how they are manufactured, their difference from generics, their exchangeability with reference products as well as the safety in clinical practice that has been observed so far. Furthermore, it was given emphasis in both parts on prescribing both biologics and biosimilars under the brand name and the necessity to create a database for the recording and monitoring of patients receiving bioimmune therapy, in order to identify any possible side effects. Finally, it was highlighted the importance of raising patients’ awareness on the issue of treatment changing, which must be in line with Greek and European guidelines.

Share Post
No Comments

Sorry, the comment form is closed at this time.